Japan to India: Ambroxol Import Trade Route

The Japan to India Ambroxol corridor is one of India's established pharmaceutical import routes from Japan, with 6 shipments documented worth a combined $475 USD. The route is dominated by TEVA TAKEDA PHARMA LTD. , which alone accounts for roughly 85% of all import value, reflecting the consolidated nature of Japan's ambroxol export sector.

Across 3 active Japan suppliers, the average shipment value stands at $79 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with ambroxol's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 21.1%, placing it at rank #9 among India's top ambroxol import origins globally.

On the Indian buyer side, key Indian importers include CHOKSI LABORATORIES LIMITED , SANOFI HEALTHCARE INDIA PRIVATE LIMITED , SANOFI HEALTHCARE INDIA PRIVATE LIMITED. CHOKSI LABORATORIES LIMITED is the single largest Indian importer with 2 shipments valued at $404 USD.

India's ambroxol imports from Japan are driven primarily by a handful of large-scale Japan manufacturers. TEVA TAKEDA PHARMA LTD. with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — Indian buyers benefit from Japan supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — TEVA TAKEDA PHARMA LTD. , SSP CO LIMITED , SSP CO LIMITED — together account for 100% of total trade value on this route. The average shipment value of $79 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as (n.c.v.) - ambroxol hydrochloride + ascorbic acid + caffeine+ chlorphenamine maleate + dihydrocodeine phosphate + ibupr and n.c.v. ambroxol hydrochloride + ascorbic acid + caffeine +chlorphenamine maleate + dihydrocodeine phosphate + ibuprof, suggesting that Indian buyers tend to consolidate orders across related product lines from the same Japan supplier.

On the buying side, CHOKSI LABORATORIES LIMITED is the largest importer with 2 shipments worth $404 USD — representing 85% of all ambroxol imports from Japan on this route.